Secondary Logo

Journal Logo

Advanced Search

Video Gallery

The role of commonly prescribed medications and weight gain in menopause- A Women’s Health Initiative study

Video Author: Fatima Cody Stanford, MD, MPH, MPA
Published on: 09.23.2020
Associated with: Menopause. 27(10):1117-1125, October 2020

This video explains how weight promoting medications may lead to weight gain in women during menopause. It should be noted that hormonal changes associated with menopause already lead to weight gain. However, weight gain may be exacerbated with the use of several commonly prescribed medications.

Related Videos

All Videos
Most Viewed
Most Emailed



Lessons learned in clinical research recruitment of midlife Latinas during COVID-19
Creator: Mayra Duran, MD and Yamnia I. Cortés, PhD, MPH, FNP-BC
Duration: 4:53
This video summarizes lessons learned in the recruitment and enrollment of midlife Latinas for a pilot study to reduce cardiovascular disease risk during the menopause transition.
Play Video |
Validation of the Menopause Transition Scale (MTS)
Creator: Missy Richeal, Leverage Marketing
Duration: 4:32
The MTS is a thorough patient-centric survey to measure symptoms of menopause as women transition in the outpatient setting.
Play Video |
The association between shift work exposure and the variations in age at natural menopause among adult Canadian workers: Results from the Canadian Longitudinal Study on Aging (CLSA)
Creator: Durdana Khan
Duration: 3:03
This video summary provides a brief overview of the research investigating associations between shift work (SW) exposure (night and rotating shift) and the variations in age at natural menopause among adult Canadian workers. Secondary data analyses were performed using the Canadian Longitudinal Study on Aging (CLSA) database. Premenopausal women at baseline were followed prospectively for three years. Our results suggest a relationship between shift work, particularly rotating shift, and delayed onset of menopause. We speculate that disruptive circadian stimuli may play a role in menopausal onset and this warrants further investigation.
Play Video |
Positive impact of a co-designed digital resource for women with early menopause
Creator: Clinical Associate Professor Amanda Vincent, Monash Centre for Health Research and Implementation, Monash University, Melbourne Australia
Duration: 4:17
Early menopause, defined as menopause before age 45 years, affects up to 12% of women. This video summarizes a study evaluating the first co-designed digital resource (www.healthtalkaustralia.org) specifically for women with early menopause.
Play Video |
Goetsch - Where does postmenopausal dyspareunia hurt?
Creator: Linda Besant
Duration: 5:47
The video introduces an article presenting data from 55 participants eligible for a randomized intervention study to treat moderate/severe postmenopausal dyspareunia. It discusses whether it deserves a broader explanation than that of atrophy. Participants described dyspareunia as “burning” and “raw.” GU examinations carefully checked for painful locations. Vulvar vestibule tenderness, rather than vaginal sensitivity, was the consistent physical finding. Liquid lidocaine could extinguish the pain. A neural phenomenon in the vestibule may be responsible for postmenopausal dyspareunia.
Play Video |
Meno presentation eVISIT
Creator: Marcus Ortega
Duration: 5:23
Pilot Study of Asynchronous Telehealth Visits Effectively Treats Overactive Bladder
Play Video |
Managing Sexual Dysfunction in Women with Cancer: A Systematic Review of the Evidence
Creator: Dr. Jennifer Marino
Duration: 2:51
This video describes a systematic review of the efficacy of available interventions for sexual dysfunction in women after cancer.
Play Video |
Toward a better measure of midlife sexual function: pooled analysis in nearly 1000 women participating in MsFLASH randomized trials
Creator: Caroline Mitchell
Duration: 5:36
In this video we discuss analysis of Female Sexual Function Index (FSFI) responses in close to 1000 women, and identify a score cutoff that more closely correlates with sexually-related personal distress (as measured by the FSDS-R) in postmenopausal and perimenopausal women.
Play Video |
Metabolic effects of menopause: a cross-sectional characterization of body composition and exercise metabolism
Creator:
Duration: 5:16
This video is a summary of the manuscript titled ‘Metabolic effects of menopause: a cross-sectional characterization of body composition and exercise metabolism.’ The video discusses briefly the background, purpose, results, and conclusions of this study. Peri-menopause may be the optimal window for intervention, and these women should aim to prevent losses of fat-free mass and decrements in metabolism by participating in resistance and high-intensity exercise.
Play Video |
Psychological Well-Being of Midlife Women
Creator: Jiwon Lee, PhD
Duration: 4:01
This study used a structural equation model to test the significance of factors associated with the psychological well-being of midlife women in South Korea based on the transactional model of stress and coping. Self-efficacy (exogenous variable) was positively associated with the psychological well-being (endogenous variable) of middle-aged women and appeared to be mediated by perceived stress, menopausal management, menopausal symptoms, and self-compassion. The predictor variables had an explanatory power of 79.5% for psychological well-being. These results can be helpful in the future development of interventions to improve psychological well-being by improving self-efficacy and coping with stress in middle-aged women.
Play Video |
Effects of E2/P4 oral capsules on bone turnover in women with vasomotor symptoms
Creator: Michael McClung, MD; Sponsored by TherapeuticsMD
Duration: 4:41
In this video, Dr. Michael McClung describes the effects of preparations combining 0.5 mg and 1.0 mg 17β-estradiol with 100 mg of progesterone on biochemical markers of bone metabolism in postmenopausal women with a uterus who were having moderate to severe vasomotor symptoms. This was a post hoc analysis in a subset of women in the REPLENISH study that evaluated the effects of these preparations on vasomotor symptoms. Both of the combined hormone preparations significantly reduced markers of bone resorption and formation at 6 and 12 months of therapy. The research described by Dr McClung suggests that these combinations of estradiol and progesterone may have skeletal benefit in addition to improving vasomotor symptoms in postmenopausal women.
Play Video |
NT-proBNP, Menopause and Heart Failure
Creator: Aniekan Akpaffiong
Duration: 4:01
The influence of early menopause on the relationship between NT-proBNP and heart failure in postmenopausal women.
Play Video |
Oral Contraceptives Tubal Ligation and AMH - Langton
Creator: Christine R. Langton
Duration: 3:28
This video provides a brief overview of research examining the association of oral contraceptives, tubal ligation, and anti-Müllerian hormone in the Nurses’ Health Study II cohort.
Play Video |
Is the cognitive performance of women sensitive to the severity of menopausal symptoms?
Creator: Mankamal Kaur
Duration: 4:54
The video summarizes the statistical methods used and the major findings of the research article entitled ‘Is the cognitive performance of women sensitive to the severity of menopausal symptoms?’. The clinical implications of the current research has also been discussed in the video.
Play Video |
Decision aids and shared decision making in urogynecology
Creator: May Wakamatsu, MD
Duration: 4:15
The video describes the importance of shared decision making and the use of decision aids with patients who are considering treatment for pelvic organ prolapse and urinary incontinence.
Play Video |
Factors affecting surgical decision making in carriers of BRCA1/2 pathogenic variants undergoing risk reducing surgery at a dedicated hereditary ovarian cancer clinic
Creator: Michelle Jacobson MD FRCSC NCM
Duration: 3:54
This video summarizes the paper entitled “Factors Affecting Surgical Decision Making in Carriers of Pathogenic BRCA1/2 Variants at a Hereditary Ovarian Cancer Clinic” and describes the role of the dedicated hereditary ovarian cancer clinic at a tertiary care centre.
Play Video |
Gastrointestinal symptoms in four major racial/ethnic groups of midlife women: race/ethnicity and menopausal status
Creator: Gayeong Kim
Duration: 6:07
The purpose of this study was to explore the associations of race/ethnicity and menopausal status to gastrointestinal (GI) symptoms experienced during the menopausal transition while considering multiple factors that could influence the symptoms.
Play Video |
Prevalence and factors associated with overactive bladder and stress urinary incontinence in the Japan Nurses' Health Study
Creator: Kazue Nagai
Duration: 5:21
Symptoms of urinary incontinence (e.g., stress urinary incontinence [SUI]) are relatively common in women. Furthermore, overactive bladder (OAB) syndrome occurs in approximately 10% of women. Symptoms of these conditions affect health-related quality of life. Therefore, a better understanding of the prevalence and associated factors of these urinary symptoms is required for improving and preventing these symptoms. This study investigated the prevalence and factors associated with urinary symptoms using cross-sectional data from the Japan Nurses’ Health Study in 12,198 women. The prevalence of OAB was 9.5%, that of SUI was 13.9%, and that of mixed urinary incontinence was 2.1%. Age 45-54 years and postmenopausal status was significantly associated with OAB, and age group (45–49 and 50–54 years), body mass index, and parous status were significantly associated with the risk of SUI.
Play Video |
Inner metacarpal bone diameter in adult women increases while bone mineral density decreases during and after menopause, assessed by Digital X Ray Radiogrammetry
Creator: Dr. Carl Samuelsson
Duration: 3:50
Overview and summary of paper regarding bone morphology parameters measured by DXR. Powerpoint video with author going through the paper. Inner diameter of metacarpals increases in a similar fashion that bone mineral density decreases. Avenue for a screening tool?
Play Video |
Subtypes in menopausal symptoms
Creator: PING LI
Duration: 04:26
This video describes research investigating the existence of significant subgroups of women with similar menopausal symptoms. There are four subtypes of menopause symptoms in middle-aged women, namely, ‘severe symptoms’, ‘dominant sleep-emotion symptoms’, ‘physical/mental exhaustion symptoms’, and ‘no symptoms’ classes.
Play Video |



Lessons learned in clinical research recruitment of midlife Latinas during COVID-19
Creator: Mayra Duran, MD and Yamnia I. Cortés, PhD, MPH, FNP-BC
Duration: 4:53
Show More 
Show Less 
This video summarizes lessons learned in the recruitment and enrollment of midlife Latinas for a pilot study to reduce cardiovascular disease risk during the menopause transition.
Play Video |
Validation of the Menopause Transition Scale (MTS)
Creator: Missy Richeal, Leverage Marketing
Duration: 4:32
Show More 
Show Less 
The MTS is a thorough patient-centric survey to measure symptoms of menopause as women transition in the outpatient setting.
Play Video |
Positive impact of a co-designed digital resource for women with early menopause
Creator: Clinical Associate Professor Amanda Vincent, Monash Centre for Health Research and Implementation, Monash University, Melbourne Australia
Duration: 4:17
Show More 
Show Less 
Early menopause, defined as menopause before age 45 years, affects up to 12% of women. This video summarizes a study evaluating the first co-designed digital resource (www.healthtalkaustralia.org) specifically for women with early menopause.
Play Video |
Goetsch - Where does postmenopausal dyspareunia hurt?
Creator: Linda Besant
Duration: 5:47
Show More 
Show Less 
The video introduces an article presenting data from 55 participants eligible for a randomized intervention study to treat moderate/severe postmenopausal dyspareunia. It discusses whether it deserves a broader explanation than that of atrophy. Participants described dyspareunia as “burning” and “raw.” GU examinations carefully checked for painful locations. Vulvar vestibule tenderness, rather than vaginal sensitivity, was the consistent physical finding. Liquid lidocaine could extinguish the pain. A neural phenomenon in the vestibule may be responsible for postmenopausal dyspareunia.
Play Video |
Managing Sexual Dysfunction in Women with Cancer: A Systematic Review of the Evidence
Creator: Dr. Jennifer Marino
Duration: 2:51
Show More 
Show Less 
This video describes a systematic review of the efficacy of available interventions for sexual dysfunction in women after cancer.
Play Video |
Metabolic effects of menopause: a cross-sectional characterization of body composition and exercise metabolism
Creator:
Duration: 5:16
Show More 
Show Less 
This video is a summary of the manuscript titled ‘Metabolic effects of menopause: a cross-sectional characterization of body composition and exercise metabolism.’ The video discusses briefly the background, purpose, results, and conclusions of this study. Peri-menopause may be the optimal window for intervention, and these women should aim to prevent losses of fat-free mass and decrements in metabolism by participating in resistance and high-intensity exercise.
Play Video |
Psychological Well-Being of Midlife Women
Creator: Jiwon Lee, PhD
Duration: 4:01
Show More 
Show Less 
This study used a structural equation model to test the significance of factors associated with the psychological well-being of midlife women in South Korea based on the transactional model of stress and coping. Self-efficacy (exogenous variable) was positively associated with the psychological well-being (endogenous variable) of middle-aged women and appeared to be mediated by perceived stress, menopausal management, menopausal symptoms, and self-compassion. The predictor variables had an explanatory power of 79.5% for psychological well-being. These results can be helpful in the future development of interventions to improve psychological well-being by improving self-efficacy and coping with stress in middle-aged women.
Play Video |
NT-proBNP, Menopause and Heart Failure
Creator: Aniekan Akpaffiong
Duration: 4:01
Show More 
Show Less 
The influence of early menopause on the relationship between NT-proBNP and heart failure in postmenopausal women.
Play Video |
Is the cognitive performance of women sensitive to the severity of menopausal symptoms?
Creator: Mankamal Kaur
Duration: 4:54
Show More 
Show Less 
The video summarizes the statistical methods used and the major findings of the research article entitled ‘Is the cognitive performance of women sensitive to the severity of menopausal symptoms?’. The clinical implications of the current research has also been discussed in the video.
Play Video |
Gastrointestinal symptoms in four major racial/ethnic groups of midlife women: race/ethnicity and menopausal status
Creator: Gayeong Kim
Duration: 6:07
Show More 
Show Less 
The purpose of this study was to explore the associations of race/ethnicity and menopausal status to gastrointestinal (GI) symptoms experienced during the menopausal transition while considering multiple factors that could influence the symptoms.
Play Video |
Prevalence and factors associated with overactive bladder and stress urinary incontinence in the Japan Nurses' Health Study
Creator: Kazue Nagai
Duration: 5:21
Show More 
Show Less 
Symptoms of urinary incontinence (e.g., stress urinary incontinence [SUI]) are relatively common in women. Furthermore, overactive bladder (OAB) syndrome occurs in approximately 10% of women. Symptoms of these conditions affect health-related quality of life. Therefore, a better understanding of the prevalence and associated factors of these urinary symptoms is required for improving and preventing these symptoms. This study investigated the prevalence and factors associated with urinary symptoms using cross-sectional data from the Japan Nurses’ Health Study in 12,198 women. The prevalence of OAB was 9.5%, that of SUI was 13.9%, and that of mixed urinary incontinence was 2.1%. Age 45-54 years and postmenopausal status was significantly associated with OAB, and age group (45–49 and 50–54 years), body mass index, and parous status were significantly associated with the risk of SUI.
Play Video |
The Women’s Study for the Alleviation of Vasomotor Symptoms (WAVS)
Creator: Physicians Committee for Responsible Medicine
Duration: 04:44
Show More 
Show Less 
Author of the Women’s Study for the Alleviation of Vasomotor Symptoms (WAVS), Neal Barnard, MD, FACC, and WAVS study participants, discuss how eating a plant-based diet, which includes soybeans, can reduce the severity and frequency of hot flashes.
Play Video |
Effect of an educational intervention on women's healthcare provider knowledge gaps about breast density, breast cancer risk, and screening
Creator: Robin Seitzman, PhD, MPH
Duration:
Show More 
Show Less 
Overview of a study to assess the effect of a web-based educational intervention on women’s healthcare provider knowledge of breast density, its risk and screening implications, and comfort level in discussing these topics with patients.
Play Video |
Equol and Obesity
Creator: Atsushi Takahashi
Duration: 3:28
Show More 
Show Less 
In this video, Dr. Takahashi provides a summary of article　“Association of equol with obesity in postmenopausal women.”
Play Video |
Dr. Juliana Kling - Good Sleep Quality Matters
Creator:
Duration: 4:52
Show More 
Show Less 
Dr. Juliana Kling, first author, describes a summary of findings from their manuscript “Associations of Sleep and Female Sexual Function: Good Sleep Quality Matters.” The evaluated potential associations between sleep (quality and duration) and sexual function using validated tools after accounting for factors that may influence both outcomes. Overall, poor sleep quality was associated with a greater risk for Female Sexual Dysfunction. While shorter sleep duration correlated with a greater risk for FSD on univariate analysis, this finding appears to be moderated by other factors known to associate with both short sleep duration and FSD. Conversely, good sleep quality was associated with sexual activity. Therefore, this study shows that sleep quality appears to be linked to female sexual function and sexual activity. In addition to its myriad effects on health, poor sleep quality may be independently associated with FSD.
Play Video |
Genitourinary syndrome of menopause: A systematic review on prevalence and treatment
Creator: Nikoletta Mili
Duration: 6:03
Show More 
Show Less 
Video summary of the article entitled “Genitourinary syndrome of menopause: A systematic review on prevalence and treatment”. This article aimed to systematically review the literature to investigate the prevalence of GSM and its treatment. GSM is a highly prevalent condition among women. Nevertheless, women are frequently not aware of its cause and its treatment options. The findings of this review underline the need for education of patients and health care professionals regarding GSM diagnosis and treatment options.
Play Video |
Hormone therapy as a possible solution for postmenopausal women with nocturia
Creator: Kim Pauwaert
Duration: 5:00
Show More 
Show Less 
Video summary for “Hormone therapy as a possible solution for postmenopausal women with nocturia: results of a pilot trial”
Play Video |
Efficacy of progesterone-only treatment for the management of menopausal symptoms: A systematic review
Creator: Sarah Sheehan Stadler, MD
Duration: 3:51
Show More 
Show Less 
Review of literature regarding progesterone only for the management of menopausal symptoms
Play Video |
The ewe as an animal model of vaginal atrophy and vaginal Er:YAG laser application
Creator: Martin Hájek
Duration: 3:46
Show More 
Show Less 
In sheep of reproductive age, we aimed to document decrease in epithelial thickness, glycogen amount and other vaginal changes after castration and the effect of Er:YAG laser as used clinically.
Play Video |
Migraine and Menopause: Introductory video
Creator:
Duration: 6:02
Show More 
Show Less 
Brief summary and key points from article
Play Video |
Improving the Identification of Genitourinary Syndrome of Menopause through the Utilization of the Day-to-Day Impact of Vaginal Aging Questionnaire
Creator: Jennie Mastroianni, DNP
Duration: 5:18
Show More 
Show Less 
Genitourinary syndrome of menopause (GSM) affects nearly 50% of postmenopausal women. Yet, it is a problem that is difficult for both providers and patients to discuss—particularly the impact of GSM symptoms on a women’s daily activities. This quality improvement project implemented the Day-to-Day Impact of Vaginal Aging (DIVA) questionnaire to improve the identification and diagnosis of GSM. Our findings support the use of the DIVA questionnaire as an efficient tool in a busy women’s health practice setting to facilitate GSM identification and diagnosis.
Play Video |
Perimenopausal vasomotor symptoms and the cortisol awakening response
Creator: Jennifer Gordon
Duration: 3:45
Show More 
Show Less 
Summary of “Perimenopausal vasomotor symptoms and the cortisol awakening response”
Play Video |
Memory and vasomotor symptoms in women with breast cancer
Creator: Pauline M. Maki, PhD., Senior Author
Duration: 4:00
Show More 
Show Less 
This video summarizes findings from a study by Fogel et al. entitled “Physiologic Vasomotor Symptoms are Associated with Verbal Memory Dysfunction in Breast Cancer Survivors”
Play Video |
The role of commonly prescribed medications and weight gain in menopause- A Women’s Health Initiative study
Creator: Fatima Cody Stanford, MD, MPH, MPA
Duration: 5:25
Show More 
Show Less 
This video explains how weight promoting medications may lead to weight gain in women during menopause. It should be noted that hormonal changes associated with menopause already lead to weight gain. However, weight gain may be exacerbated with the use of several commonly prescribed medications.
Play Video |
A multicenter, randomized study to select the minimum effective dose of estetrol (E4) in postmenopausal women (E4Relief) on vasomotor symptoms
Creator: Mithra Pharmaceuticals (sponsor)
Duration: 4:29
Show More 
Show Less 
This video summarizes the results of a study to select the minimum effective dose of estetrol (E4) for the treatment of postmenopausal women with vasomotor symptoms (VMS, hot flushes). The reduction in frequency and severity of VMS was most pronounced for 15 mg E4, and was significant at week 4 and 12. E4 was well tolerated and there were no unexpected adverse events. It was concluded that oral E4 15 mg is the minimum effective daily oral dose for treatment of VMS.
Play Video |
Introduction to the Role of Sex Steroid Hormones in Pelvic Organ Prolapse
Creator: Christina Dancz, MD
Duration: 2:54
Show More 
Show Less 
In this video abstract, Dr. Christina Dancz from the Keck School of Medicine of the University of Southern California (USC) comments on the role of sex steroid hormones in pelvic organ prolapse. More specifically, she introduces the viewer to the effects of estrogen and progestin on ligament strength, tissue remodeling, the extracellular matrix, and clinical presentation. Taken altogether, these findings suggest that there may be a role for the exogenous administration of hormones in the prevention of pelvic organ prolapse. This topic is more fully explored in our published review in Menopause.
Play Video |
“Associations of Pituitary-Ovarian Hormones and White Matter Hyperintensities in Recently Menopausal Women using Hormone Therapy.”
Creator: No sponsor
Created by Mayo Clinic
Duration: 4:22
Show More 
Show Less 
The video reviews the findings from our paper entitled “Associations of Pituitary-Ovarian Hormones and White Matter Hyperintensities in Recently Menopausal Women using Hormone Therapy.” In recently menopausal women participating in the Kronos Early Estrogen Prevention Study (KEEPS), greater increases in estrone associated with smaller increases in WMH volume in both the transdermal estradiol and oral conjugated equine estrogen groups. In addition, greater decreases in FSH associated with smaller increases in WMH volume over time but only in women using the transdermal estrogen. Our results demonstrate that the type of hormone therapy used during menopause contributes to different levels of circulating hormones which then may have different impact on brain structure during treatment.
Play Video |
Depression, hormone therapy and the menopausal transition among women aged 45-64 years using Canadian Longitudinal Study on Aging baseline data
Creator: Alison Shea
Duration: 5:07
Show More 
Show Less 
The menopause transition is a vulnerable time for mental health and it is important to better understand the risk factors for depression during this time. This study using baseline data from the Canadian Longitudinal Study on Aging shows that premature menopause and the use of hormone therapy, as well as low education, low household income, living alone, being nulliparous, and having low social support are associated with current depression measured using the Center for Epidemiologic studies Short Depression Scale.
Play Video |
Mental well-being and menopause
Creator: Dmitriy Bondarev
Duration: 4:32
Show More 
Show Less 
Mental well-being and menopause
Play Video |
Uterine Fibroids in Menopause and Perimenopause
Creator: Paige Wynne
Video Production Specialist
Creative and Digital Services
University of Illinois at Chicago
Duration: 3:34
Show More 
Show Less 
In this video, we glimpse the significance of Uterine fibroid disease and highlights their unusual persistence in menopause women. Moreover, we discuss the possible available treatment options as well as the advantages and disadvantages of using hormonal therapy in this specific population.
Play Video |
A Question Prompt List for Early Menopause
Creator: Melanie Gibson-Helm
Duration: 4:01
Show More 
Show Less 
In this video we describe a multiple-methods study to develop a Question Prompt List (QPL) for Early Menopause. The research resulted in a QPL for Early Menopause that is stakeholder informed, evidence-based, acceptable to women, and feasible to use in a clinic setting.
Play Video |
What do healthcare professionals and high-risk women need to know about risk-reducing salpingo-oophorectomy?
Creator: Martha Hickey
Duration: 6:46
Show More 
Show Less 
What do healthcare professionals and high-risk women need to know about risk-reducing salpingo-oophorectomy?
Play Video |
Hysterectomy and its association with Mental Health
Creator: Shannon Laughlin-Tommaso
Duration:
Show More 
Show Less 
In this video, we discuss how hysterectomy, even with ovarian conservation, increased the long-term risks of depression and anxiety by over 20% compared with referent women. In this population-based cohort with 20 years of follow-up, hysterectomy with ovarian conservation was associated an absolute risk increase of 7% for depression and 5% for anxiety. Women who had a hysterectomy before age 36 had even higher absolute risk increases: 12% for depression and 10% for anxiety.
Play Video |
Yearly zoledronic acid use in combination of proper self-oral hygiene management for osteoporosis patients can prevent symptomatic periodontal disease
Creator: Akira Taguchi
Duration: 4:23
Show More 
Show Less 
Bisphosphonate is the first line agent for osteoporosis, although We have been worried about the occurrence of severe adverse event associated with bisphosphonate on oral cavity, osteonecrosis of the jaws (ONJ). Also, periodontal disease, especially is the important risk factor for ONJ. The aim of this study was to determine whether once-yearly zoledronic acid in combination with proper self-oral hygiene management can improve symptomatic periodontal disease compared with placebo. Our results suggest that bisphosphonate use in combination of proper self-oral hygiene management for osteoporosis patients can prevent symptomatic periodontal disease, resulting in the risk reduction of bisphosphonate-related ONJ.
Play Video |
Are women still sexually active after menopause?
Creator: Sussex Health Outcomes Research & Education in Cancer; filmed and edited by Matt Bemment, Communication Assistant, Brighton and Sussex Medical School
Duration: 4:35
Show More 
Show Less 
What do we really know about sex after menopause? This video summary reports on the results of a free-text analysis on sexual activity in over 4,400 postmenopausal women who took part in UKCTOCS, a large UK ovarian cancer screening trial. It shows that sexuality can change when we get older and that relationship status and health have a direct effect on sexuality and satisfaction. We believe it is important to raise awareness among women and healthcare professionals to increase the understanding of sexual issues women may face in later life.
Play Video |
Visual Assessment of Genital Health in Menopausal Women
Creator: Irwin Goldstein, MD
Duration: 3:48
Show More 
Show Less 
This is a phase 3 pivotal trial of ospemifene versus placebo in women in menopause with moderate to severe vaginal dryness, a symptom of GSM. On physical examination, such women commonly have vulvar, vestibular and vaginal atrophy. This study, for the first time, utilized vulvar vestibular photography to objectively document changes in genital health. There were no changes noted in photography on placebo, however active therapy with a SERM resulted in regrowth of labia minora, normalization of the urethral gland prominence, resolution of the pallor and erythema of the vestibule and visualization of vestibular moisture. Visual assessment of genital health in such patients should be utilized in future trials.
Play Video |
Validation of the CBT-Meno Protocol: A summary of a recent RCT
Creator: Eleanor Donegan, Ph.D., C.Psych.
Duration: 3:03
Show More 
Show Less 
The menopausal transition is associated with a number of adverse changes for many women, including vasomotor and depressive symptoms, anxiety, poor sleep, urogenital and sexual concerns. Pharmacotherapy is effective but can be associated with health-related concerns for some women and there is a need for non-pharmacological interventions that target a range of menopausal symptoms. Our research group developed a new cognitive behavioral therapy protocol (CBT-Meno) to target a range of commonly-reported menopausal symptoms. In this video, we summarize the results of a recent randomized controlled trial evaluating the effectiveness of the CBT-Meno protocol compared to a waitlist condition.
Play Video |